<DOC>
	<DOCNO>NCT01892384</DOCNO>
	<brief_summary>The primary objective current study investigate safety tolerability BI 409306 schizophrenic patient follow oral administration multiple low , medium , high dos 14 day . A secondary objective exploration pharmacokinetics pharmacodynamics BI 409306 schizophrenic patient .</brief_summary>
	<brief_title>Safety Tolerability BI 409306 Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients establish diagnosis schizophrenia ( per Diagnostic Statistical Manual Mental Disorders ( DSMIV ) ) follow clinical feature : 1 . Clinically stable residual ( nonacute ) phase illness least 8 week . 2 . Maintained current antipsychotic medication current dose least 8 week . 3 . Have moderate severity rating hallucination delusion ( e.g . Brief Psychiatric Rating Scale ( BPRS ) Hallucinatory Behavior Unusual Thought Content item score &lt; =4 ) . 4 . Have moderate severity rating positive formal think disorder ( e.g . BPRS Conceptual Disorganization item score &lt; =4 ) . 5 . Have moderate severity rating negative symptom ( Positive Negative Syndrome Scale negative syndrome total score &lt; 15 ) . 6 . Have minimal level extrapyramidal symptom ( e.g . SimpsonAngus Scale total score &lt; 6 ) depressive symptom ( e.g . Calgary Depression Scale total score &lt; 10 ) . 2 . Male female patient age &gt; = 18 &lt; =55 year . 3 . Patients must exhibit reliability physiologic capability comply protocol procedure . 4 . Signed date write informed consent prior admission study accordance GCP local legislation . If patient need legal representative , legal representative must give write consent well . Exclusion criterion : 1 . Patient treat one antipsychotic stabilize antipsychotic treatment , electroconvulsive therapy within last 30 day 2 . Patient 's cognitive impairment severity compromise validity cognitive outcome measure , clinical judgment investigator . 3 . Any suicidal behavior past 2 year ( i.e . actual attempt , interrupt attempt , abort attempt , preparatory act behavior ) . 4 . Any suicidal ideation type 4 5 Columbia Suicidal Severity Rating Scale ( CSSRS ) past 3 month ( i.e . active suicidal think intent without specific plan , active suicidal think plan intent ) . 5 . Any finding medical examination ( include BP , PR ECG ) laboratory value deviate normal clinical relevance judgment investigator . 6 . Any evidence clinically relevant concomitant disease . 7 . History diagnosis symptomatic unstable/uncontrolled gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological , haematological hormonal disorder . 8 . Female patient childbearing potential currently breastfeed . 9 . Known history , new diagnosis per screen lab , HIV infection . 10 . History neurologic ( e.g . stroke , seizure without clear resolve etiology , concussion accompany loss consciousness ) psychiatric condition investigator deems may interfere interpretability data 11 . History malignancy within last 5 year , except basal cell carcinoma . 12 . Planned elective surgery require general anaesthesia , hospitalisation 1 day study period . 13 . Any clinical condition , opinion investigator , would jeopardize patient 's safety participate clinical trial . 14 . Significant history drug dependence abuse ( include alcohol , define Diagnostic Statistical Manual Mental Disorders ( DSMIV ) opinion investigator ) within last two year prior inform consent , positive urine drug screen cocaine , opioid , phencyclidine ( PCP ) , amphetamine marijuana screening . 15 . Participation another trial investigational drug procedure within 30 day prior screen previous participation BI 409306 study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>